|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Liver Diseases | |||||
| 2 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Pioglitazone | |||||
| Vitamin E | |||||
| Matching placebo | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Alpha-Tocopherol | |||||
| Tocopherol acetate | |||||
| Tocopherols | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antioxidants | |||||
| Growth Substances | |||||
| Hypoglycemic Agents | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||